Autosomal Recessive Conditions
Cystic Fibrosis
Cystic Fibrosis is an autosomal recessive disorder that affects many different areas of the body including the lungs, digestive system, and fertility. Cystic Fibrosis does not affect intelligence. Signs and symptoms of Cystic Fibrosis start in early childhood and include delayed growth caused by problems in digestion and repeated lung infections that lead to permanent lung damage. Children and adults with Cystic Fibrosis usually have frequent hospitalizations because of lung infections. Over time, complications of Cystic Fibrosis can lead to lung transplants and early death. There are treatments for Cystic Fibrosis that can lessen the severity of the symptoms; however, there is currently no cure.
Cystic Fibrosis is caused by a change, or mutation, in both copies of the CFTR gene pair. These mutations cause the genes to not work properly or not work at all. When both copies of this gene do not work correctly, mucus and other body fluids become thick and sticky. This causes problems with how the lungs, digestive system, and other body systems function and leads to the symptoms described above. Although most CFTR gene mutations cause classic CF, there are some specific CFTR mutations that cause less severe symptoms, and some only affect male fertility. A small number of CF carriers may have mild respiratory or other symptoms.
Duchenne/Becker Muscular Dystrophy
Duchenne and Becker Muscular Dystrophy are inherited disorders called “Dystrophinopathies” that cause progressive breakdown and weakness of both skeletal and heart muscle. In Duchenne Muscular Dystrophy, the muscle weakness usually begins around 3 to 5 years of age and worsens over time. By the teenage years, the muscle degeneration and weakness also starts to involve the muscles of the lungs and heart. In Becker Muscular Dystrophy, the signs and symptoms are milder and begin later in childhood. For both conditions, it is more common for boys to be affected than girls. Children and adults with Duchenne/Becker Muscular Dystrophy need physical and occupational therapy and lifelong medical treatment. Most boys with Duchenne Muscular Dystrophy will need a wheelchair by their mid to late teenage years; boys with Becker Muscular Dystrophy are often in their late teens or early adulthood before they need a wheelchair. A variable degree of intellectual disability may occur and is more common in children with Duchenne than in children with Becker. Presently there is no cure for Duchenne/Becker Muscular Dystrophy. With current medical treatments, survival is common into the 20s and 30s with Duchenne Muscular Dystrophy and into the 40s with Becker Muscular Dystrophy. Some males have a separate form of Dystrophinopathy called DMD-Associated Dilated Cardiomyopathy, which does not include skeletal muscle weakness. DMD-Associated Dilated Cardiomyopathy causes progressive heart problems where one or more chambers of the heart dilate, the heart muscle weakens, and congestive heart failure occurs. Symptoms typically start between the ages of 20 and 40 years and lifespan is shortened. About 1 in every 3500 males is born with Duchenne Muscular Dystrophy and about 1 in every 18,500 boys is born with Becker Muscular Dystrophy. DMD-Associated Dilated Cardiomyopathy is rare.
Some female carriers develop heart problems such as dilated cardiomyopathy and some have other symptoms of Duchenne/Becker Muscular Dystrophy such as mild to moderate muscle weakness. In rare cases, female carriers may have more serious symptoms.
Duchenne/Becker Muscular Dystrophy is caused by a change, or mutation, in the DMDgene. This mutation causes the gene to not work properly or not work at all. When this gene does not work correctly, it leads to a lack of dystrophin, a protein normally found in muscle cells. Muscle cells in the skeleton and heart that don’t have enough dystrophin gradually stop working, leading to the symptoms described above. It is sometimes but not always possible to tell just by the mutation whether a boy will have the Duchenne or Becker form of this condition.
Fragile X Syndrome
Fragile X Syndrome is an X-linked inherited disorder. It is the most common inherited cause of intellectual disability and occurs in about 1 in 4000 males and 1 in 8000 females. Boys with Fragile X Syndrome typically have more serious learning and behavior problems than girls. On average, boys have moderate to severe intellectual disability. Behavior and emotional problems are common, and autism spectrum disorder is sometimes present. Symptoms in girls can range from none to severe intellectual disability; however, they are most likely to be mild. At this time there is no cure for Fragile X Syndrome and treatment is based on symptoms.
Fragile X Syndrome is caused by a mutation (change) in the FMR1 gene known as a CGG repeat. Humans typically have between 6 and 44 copies of CGG in the FMR1 gene. In people with Fragile X Syndrome, there are more than 200 copies of CGG. The large number of repeated CGGs causes the gene to turn off and not work properly. This leads to the specific set of learning and development problems found in Fragile X Syndrome.
A carrier for Fragile X Syndrome is someone who has a mutation (change) in one FMR1 gene. This change is called a ‘premutation’ and has between 55 and 200 CGG copies. Women who are premutation carriers have an increased chance of having children affected with Fragile X Syndrome. Occasionally, females with a premutation may have issues related to attention span such as Attention Deficit Disorder and some may have behavior problems, social anxiety, and/or difficulty with social skills. Males with a premutation tend to have a higher rate of these types of problems.
Spinal Muscular Atrophy
Spinal Muscular Atrophy, also called SMA, is a serious autosomal recessive disorder that typically begins in infancy or childhood and causes worsening muscle weakness, decreased ability to breathe, and loss of motor skills. Most children with Spinal Muscular Atrophy have one of the early-onset forms with symptoms that begin in infancy, with death often occurring before the age of two. Some children have juvenile-onset SMA and develop muscle weakness and other symptoms later in childhood. In rare cases, symptoms do not begin until early adulthood, are less severe, and do not affect lifespan. Currently there is no cure for Spinal Muscular Atrophy, although treatments are available that may lessen some of the symptoms in some patients.
Spinal Muscular Atrophy is caused by a change, or mutation, in both copies of the SMN1 gene pair. These mutations, which often delete part or all of these genes, cause the genes to work improperly or not work at all. When both copies of the SMN1 gene are missing or do not work correctly, it leads to the symptoms described above